Related Experiment Videos
Continuation of warfarin-nafcillin interaction during dicloxacillin therapy
A T Taylor1, D C Pritchard, A O Goldstein
1Department of Pharmacy Practice, University of Georgia College of Pharmacy, Athens.
Abstract:
Interactions between warfarin and penicillins have been infrequently reported. A case report of a single patient who experienced the effects of a warfarin-nafcillin interaction as well as a warfarin-dicloxacillin interaction is presented. Clinical effects of this interaction were documented primarily through changes in prothrombin time (PT) and the need for higher warfarin dosing. While the patient received nafcillin, warfarin doses were increased to as much as 4.5 times the previous amounts needed to provide adequate anticoagulation. During dicloxacillin therapy, warfarin doses were gradually decreased, but stabilized to a maintenance dose higher than the patient's pre-nafcillin dose. The dicloxacillin-warfarin interaction appears similar to that noted during nafcillin-warfarin combination.
Insights
Warfarin drug interactions with nafcillin and dicloxacillin require significantly higher warfarin doses. This case report highlights potential risks and management adjustments for anticoagulation therapy during penicillin co-administration.
Area of Science:
- Pharmacology and Drug Interactions
- Clinical Pharmacy
Background:
- Warfarin is a widely used anticoagulant, necessitating careful management of drug interactions.
- Interactions between warfarin and penicillinase-resistant penicillins are infrequently documented.
- Understanding these interactions is crucial for maintaining therapeutic anticoagulation.
Observation:
- A single patient case involving concurrent warfarin and nafcillin therapy is presented.
- The patient subsequently received warfarin and dicloxacillin, allowing for comparative analysis.
- Clinical effects were monitored via prothrombin time (PT) and warfarin dosage requirements.
Findings:
- Nafcillin therapy necessitated up to a 4.5-fold increase in warfarin dosage for adequate anticoagulation.
- Dicloxacillin therapy also required increased warfarin dosing, though it was gradually reduced.
- The stabilized warfarin maintenance dose remained higher than the pre-nafcillin baseline.
Implications:
- Nafcillin and dicloxacillin may significantly reduce warfarin's anticoagulant efficacy.
- Close monitoring of PT and warfarin dosage adjustments are essential during co-administration.
- These findings suggest a clinically relevant interaction between these penicillins and warfarin.